Cellular

Targeting mitochondria to fight aging

New study shows that two experimental drugs can reverse age-related cognitive impairment and potentially treat Alzheimer's disease, by restoring mitochondrial function in the aging...

UK Gov releases human germline editing brief

Human Germline Genome Engineering is a highly controversial area – altering genes so that changes are passed on to all descendants.  Just because we...

Evolution 2.0 prize: The $10 million question

Major new prize announced to help identify how cells intentionally self-organise and communicate; George Church part of judging panel. The origin of life is often...

Ageotype: Four new types of biomarker

You’ve obviously heard of stereotype. But how about an ageotype? Scientists have identified at least four types of aging, which could explain why we...

Latest articles

Insurer puts-down £20m to research an aging rethink

A new partnership between Legal & General and Edinburgh University aims to address the societal and economic implications of an aging society. The world is...

23andMe redundancies: DNA test market decline?

Could layoffs at 23andMe be a sign that the consumer appetite for genetic testing is declining? We expect consumer markets to transition to more...

Singapore agetech – ones to watch in 2020

Singapore thrives on its prime location at the crossroads of Asia's biggest markets, low business tax and great IT infrastructure; it is well-positioned to...

Innovating organ-on-chip to accelerate research

BIOFABICS brings custom design tools to biofabrication. While still in its infancy, organ-on-chip (OOC) technology is quickly becoming a key growth segment in the Longevity...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.